Rad51 activators represent a compelling class of chemicals that function by inducing changes in cellular DNA, prompting the activation of Rad51 for DNA repair mechanisms. They range from DNA-damaging agents like olaparib and zeocin to replication inhibitors such as hydroxyurea and aphidicolin. For instance, DNA-damaging agents like mitomycin C and cisplatin introduce modifications or lesions in the DNA structure. These alterations trigger the DNA damage response pathways, culminating in the activation of Rad51 to facilitate homologous recombination-based DNA repair. In the context of replication inhibitors, chemicals like hydroxyurea and aphidicolin stall the replication forks, creating an environment that necessitates the activation of Rad51 to stabilize these stalled forks.
Another facet of Rad51 activators includes chemicals like etoposide and camptothecin, which target specific DNA metabolic enzymes. Etoposide interferes with the function of topoisomerase II, inducing DNA breaks that lead to the recruitment and activation of Rad51. Camptothecin disrupts topoisomerase I activity, resulting in DNA strand breaks that similarly necessitate Rad51 activation. The diversity in chemical structures and mechanisms of action among these compounds highlights the complexity of cellular processes that are geared to maintain DNA integrity. Through various mechanisms, these chemicals succeed in activating Rad51, emphasizing the protein's central role in cellular DNA repair pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C introduces interstrand crosslinks in DNA that can activate Rad51 for DNA repair. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin binds to DNA and triggers a response that includes the activation of Rad51. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil results in thymidine deficiency, increasing DNA breaks and necessitating the activation of Rad51. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine incorporates into DNA, causing perturbations that can activate Rad51. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin inhibits DNA polymerase, leading to stalled replication forks and the activation of Rad51. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin targets topoisomerase I, causing DNA damage that activates Rad51 for repair. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin induces DNA damage that leads to activation of Rad51 for repair mechanisms. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide interferes with topoisomerase II, resulting in DNA breaks and thus activation of Rad51. | ||||||
4-Nitroquinoline N-oxide | 56-57-5 | sc-256815 sc-256815A | 1 g 5 g | $124.00 $421.00 | 6 | |
4-NQO introduces DNA adducts and double-strand breaks, leading to Rad51 activation. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor that activates Rad51 by increasing DNA damage, which in turn stimulates the Rad51-dependent homologous recombination. | ||||||